Mr. Dennis Hancock reports

MOUNTAIN VALLEY MD ANNOUNCES APPOINTMENT OF NEW CFO

Mountain Valley MD Holdings Inc. has appointed Lucie Letellier to the role of chief financial officer, effective Sept. 11, 2023. Ms. Letellier succeeds Aaron Triplett, who previously served as chief financial officer and will remain as a non-executive consultant of the company through Nov. 30, 2023, to ensure a seamless transition.

"I am very pleased to welcome Lucie Letellier to this important role and look forward to capitalizing on her leadership and expertise to support MVMD's commercialization growth phase and the scaling of our operations," said Dennis Hancock, president and chief executive officer of the company. "Ms. Letellier's proven track record of results-driven leadership, strategic thinking and financial acumen comes at an important time for MVMD as we navigate complex international sales, royalty and tax strategies."

With a distinguished financial career spanning more than 25 years, Ms. Letellier brings a wealth of expertise in public markets and international business. Ms. Letellier originally served as the chief financial officer of Mountain Valley MD Inc. (Mountain Valley's wholly owned subsidiary), where she skillfully navigated a complex reverse takeover (RTO) transaction in February, 2020, and led multiple financing rounds in the establishment of the business. Ms. Letellier transitioned into an advisory role with the company in May of 2020 as she took a leave of absence from full-time responsibilities to prioritize family commitments. Her extensive financial expertise has been showcased in numerous roles over her career, including CFO of Paramount Gold and Silver Corp. At Paramount Gold, she supported the company's growth, overseeing $30-million in equity financing, which ultimately led to its acquisition by Coeur Mining for $200-million. Her extensive experience includes key financial leadership positions in various multinational corporations across numerous stock exchanges, including CFO roles at Crestwell Resources, Everton Resources Inc. and Albert Mining Inc.

"Ms. Letellier brings a deep understanding of financial reporting for both U.S. and Canadian public companies, tax compliance, corporate governance, and continuous disclosure requirements," continued Mr. Hancock. "Ms. Letellier's ability to navigate diverse regulatory environments, manage currency fluctuations and adapt to cultural nuances across international markets will be invaluable on our leadership team."

The company has granted stock options to Ms. Letellier in accordance with the terms and conditions of the company's stock option plan to purchase 500,000 common shares in the capital stock of the company. The options are exercisable for a period of five years from the date of grant at a price of five cents per share. The options will vest 20 per cent on the date of grant, 30 per cent on the six-month anniversary following the date of grant and the remaining 50 per cent on the 12-month anniversary following the date of grant.

The company extends its appreciation to the outgoing CFO, Mr. Triplett, for his extensive contributions to the company's development and providing financial leadership in a challenging start-up environment, and wishes him well in his new endeavours.

About Mountain Valley MD Holdings Inc.

Mountain Valley is building a world-class organization centred around the implementation, licensing and reselling of key technologies and formulations:

• Patented Quicksome oral formulation and delivery technologies;
• Patented Quicksol solubility formulation technology;
• Licensed product reseller of Agrarius, a novel agricultural plant signalling technology.

Consistent with its vision toward more life, Mountain Valley applies its owned and licensed technologies to its work for advanced delivery of molecules for human and husbandry animal applications, including the development of products for pain management, weight loss, energy, focus, sleep, anxiety and more. Additionally, Mountain Valley's work with Agrarius is focused on generating a positive impact on crop yields and reducing fertilizer usage.

Mountain Valley's patented Quicksome technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats. The result is a new generation of product formulations that could be capable of delivering nutraceutical and drug molecules into the body faster, with greater impact, efficiency and accuracy.

Mountain Valley's patented Quicksol technology covers all highly solubilized macrocyclic lactones that could be effectively applied in multiple viral applications that could positively impact human and animal health globally.

Mountain Valley's licensed Agrairus agricultural plant signalling technology that could be capable of application to agricultural crops to naturally increase yields, reduces fertilizer usage and increases general resilience to pests and climate change.

We seek Safe Harbor.